Journal of Cancer Clinical Trials

ISSN: 2577-0535

Open Access

Aparna Jayachandran

Department of Molecular medicine, Gallipoli Medical Research Institute, Greenslopes Clinical School, The University of Queensland, Brisbane, Australia

  • Mini Review   
    Breast Cancer Therapy
    Author(s): Aparna Jayachandran*

    Family physicians can better care for their patients throughout and after cancer treatment if they are aware of the available breast cancer treatments. According to stage, histology, and biomarkers, this article summarises standard treatments. Treatment is not necessary for lobular cancer in situ. Without further lymph node exploration or systemic therapy, invasive ductal carcinoma in situ is treated with breast-conserving surgery and radiation therapy. Breast-conserving surgery and radiation therapy are typically used to treat breast cancer in stages I and II. Radiation therapy reduces mortality and recurrence after breast-conserving surgery. For the majority of breast cancers with clinically negative axillary lymph nodes, sentinel lymph node biopsy is an option because it does not cause the arm pain and swelling that come with axillary lymph node dissection. ERBB.. Read More»
    DOI: 10.37421/2577-0535.2022.7.184

    Abstract HTML PDF

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 85

Journal of Cancer Clinical Trials received 85 citations as per Google Scholar report

Journal of Cancer Clinical Trials peer review process verified at publons

Indexed In

arrow_upward arrow_upward